Neonatal outcomes following new reimbursement limitations on palivizumab in Italy | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

XML

Drug therapy

Original article

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy

Online download statistics by month:

Online download statistics by month: September 2018 to April 2023

	Abstract	Full	Pdf
Sep 2018	389	384	93
Oct 2018	320	316	75
Nov 2018	399	392	87
Dec 2018	295	288	56
Jan 2019	139	129	16
Feb 2019	70	66	9
Mar 2019	73	64	18
Apr 2019	81	75	15
May 2019	35	34	12
Jun 2019	37	33	10
Jul 2019	39	37	14
Aug 2019	57	44	11
Sep 2019	64	60	13
Oct 2019	65	45	13
Nov 2019	36	32	11
Dec 2019	23	20	4
Jan 2020	40	36	8
Feb 2020	44	42	7
Mar 2020	49	48	7
Apr 2020	31	31	20
May 2020	25	23	11
Jun 2020	22	21	6
Jul 2020	15	14	9
Aug 2020	22	14	11
Sep 2020	35	31	28
Oct 2020	29	20	9
Nov 2020	24	18	8
Dec 2020	15	14	8
Jan 2021	19	18	5
Feb 2021	12	11	3
Mar 2021	23	23	5
Apr 2021	19	18	6
May 2021	21	20	15
Jun 2021	23	20	4
Jul 2021	22	20	13
Aug 2021	12	10	10
Sep 2021	29	28	6
Oct 2021	29	26	25
Nov 2021	43	42	19
Dec 2021	15	14	1
Jan 2022	24	23	8
Feb 2022	17	16	8
Mar 2022	20	19	9
Apr 2022	19	19	8
May 2022	34	34	18
Jun 2022	29	29	9
Jul 2022	21	20	7
Aug 2022	33	32	11
Sep 2022	37	37	17
Oct 2022	50	48	30
Nov 2022	21	20	7
Dec 2022	17	13	21
Jan 2023	16	15	10
Feb 2023	22	23	3
Mar 2023	23	22	7
Apr 2023	2	2	2
Total	3125	2953	876